Legal & General Group Plc lessened its position in Ralliant Corporation (NYSE:RAL – Free Report) by 50.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 285,294 shares of the company’s stock after selling 290,139 shares during the period. Legal & General Group Plc’s holdings in Ralliant were worth $14,524,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Allworth Financial LP boosted its position in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares during the last quarter. Keybank National Association OH raised its holdings in Ralliant by 1.6% in the 4th quarter. Keybank National Association OH now owns 19,667 shares of the company’s stock valued at $1,001,000 after acquiring an additional 305 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its stake in shares of Ralliant by 1.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 25,800 shares of the company’s stock worth $1,313,000 after purchasing an additional 400 shares during the period. Arizona State Retirement System lifted its stake in shares of Ralliant by 1.2% during the 3rd quarter. Arizona State Retirement System now owns 33,566 shares of the company’s stock worth $1,468,000 after purchasing an additional 413 shares during the period. Finally, Danske Bank A S acquired a new stake in shares of Ralliant during the fourth quarter worth $25,000.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the company. Oppenheimer lifted their price objective on Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Vertical Research lowered Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 27th. TD Cowen increased their price objective on shares of Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, May 20th. Barclays raised their target price on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 13th. Finally, Morgan Stanley boosted their target price on shares of Ralliant from $45.00 to $68.00 and gave the company an “overweight” rating in a report on Thursday, May 14th. Six investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Ralliant has a consensus rating of “Hold” and a consensus price target of $64.50.
Insider Buying and Selling at Ralliant
In related news, SVP Karen M. Bick sold 2,530 shares of Ralliant stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the completion of the transaction, the senior vice president directly owned 42,652 shares in the company, valued at approximately $1,983,318. This trade represents a 5.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.42% of the company’s stock.
Ralliant Stock Up 0.7%
Shares of Ralliant stock opened at $61.88 on Wednesday. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $63.31. The stock has a market cap of $6.93 billion and a price-to-earnings ratio of -5.66. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.73. The company has a fifty day moving average price of $49.18 and a 200 day moving average price of $48.81.
Ralliant (NYSE:RAL – Get Free Report) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The firm had revenue of $534.60 million for the quarter. Ralliant’s revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Equities research analysts forecast that Ralliant Corporation will post 2.64 earnings per share for the current fiscal year.
Ralliant Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 8th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s dividend payout ratio (DPR) is currently -1.83%.
Ralliant Profile
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Stories
- Five stocks we like better than Ralliant
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
